Board Certifications: Internal Medicine (1998); Endocrinology, Diabetes & Metabolism (2001)
Experience: 27 years | Location: Chennai, India
Education: MBBS, Madras Medical College (1995); MD Internal Medicine, CMC Vellore (1998); DM Endocrinology, AIIMS New Delhi (2001); Advanced Diabetes Management, Joslin Diabetes Center, Harvard (2005)
Dr. Vikram Nair is one of South India's most experienced endocrinologists, with an exceptional 27-year career managing complex hormonal disorders and pioneering Type 2 diabetes reversal protocols. Having treated over 30,000 diabetic patients and performed more than 5,000 thyroid ultrasounds, Dr. Nair brings unparalleled clinical depth to metabolic disease management.
After completing his DM in Endocrinology at AIIMS, Dr. Nair pursued specialized training at Harvard's Joslin Diabetes Center, where he studied intensive insulin therapy and continuous glucose monitoring systems. His groundbreaking work on diabetes remission through very-low-calorie diets and bariatric surgery has been published in Diabetes Care, The Lancet Diabetes & Endocrinology, and the Journal of Clinical Endocrinology & Metabolism.
Dr. Nair established Chennai's first comprehensive diabetes care center in 2008, integrating endocrinology, nutrition counseling, and diabetes education under one roof. His patient outcomes consistently exceed national benchmarks, with 78% of his Type 2 diabetes patients achieving HbA1c targets compared to the national average of 35%.
Beyond clinical practice, Dr. Nair is a passionate medical educator who conducts monthly continuing education sessions for primary-care physicians across Tamil Nadu on topics including insulin optimization, thyroid nodule management, and adrenal disorders. He has trained over 400 doctors through his CME programs and has served as an examiner for the National Board of Examinations in Endocrinology.
As Senior Endocrinology Advisor at My Medicine Advisor, Dr. Nair ensures all diabetes, thyroid, and hormone-related content reflects cutting-edge evidence and practical clinical wisdom. He is actively researching the role of intermittent fasting in metabolic syndrome reversal and serves on the scientific advisory board of the Endocrine Society of India.
Professional Affiliations: Endocrine Society (USA); American Diabetes Association; Endocrine Society of India; Indian Thyroid Society
Publications: 6 book chapters on diabetes management
Awards: Lifetime Achievement Award, Endocrine Society of India (2023); Best Endocrinologist Award, Tamil Nadu Medical Council (2018, 2022)
Languages: English, Hindi, Tamil, Malayalam
Knows about: Type 2 diabetes reversal and management; thyroid disorders (hypothyroidism, hyperthyroidism, nodules); insulin pump therapy and CGM; polycystic ovary syndrome (PCOS); metabolic syndrome; osteoporosis and bone health; pituitary and adrenal disorders; obesity medicine
Minoxidil and finasteride work — but a new 2026 pipeline drug is outperforming both with 85% regrowth in clinical trials. We rank every balding treatment from topicals to transplants by real results, cost, and side effects so you know exactly what to ask your dermatologist.
Hair loss affects 85% of men and 33% of women — but most cases are reversible. Discover the exact treatment steps doctors recommend in 2026 before your window closes.
Every DHT blocker ranked by doctors — from finasteride to natural saw palmetto. Includes 2026 clascoterone trial data, side effects & women's options.
Pancreatic cancer survival has nearly doubled to 13% in 2026 — and new mRNA vaccines plus KRAS breakthroughs are pushing that number higher. See survival rates by stage, the 7 early warning signs doctors consistently overlook, and which new 2026 treatments are giving patients and families genuine reason for hope.
Multiple myeloma is no longer the death sentence it once was — 2026 CAR-T breakthroughs have pushed 5-year survival to 62.4%, the biggest jump in decades. See survival rates by stage, which new FDA-approved therapies are changing outcomes, and the exact questions to bring to your next oncology appointment.
Blood cancer affects 1.24M people annually. Learn the 12 early warning signs, 2026 survival rates (up to 90% for some types), and breakthrough CAR T-cell therapies offering new hope for patients.
Discover 2026 bile duct cancer survival rates by stage, recognize 7 critical warning signs early, and explore breakthrough treatments including liver transplant protocols achieving 65% cure.
Hip replacement surgery has changed dramatically in 2026 — robotic-assisted procedures now cut recovery from 12 weeks to just 6 for eligible patients. See the full week-by-week recovery timeline, real $35K–$65K cost breakdown with Medicare coverage, and the complication rates that change depending on whether your surgeon uses robotic or traditional technique.
VSG surgery in 2026: $15K-$25K average cost, 2-4 week recovery, 60-70% weight loss. Doctors skip discussing hair loss, lifelong vitamin costs & 12% revision rate.
Achieve 77% excess weight loss with bariatric surgery. Complete 2026 guide covers gastric sleeve, bypass & band procedures, real costs, insurance navigation, and success rates.